Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
Breast density is most often discussed within the context of cancer risk, but new research suggests that it also could be used as a marker of cardiometabolic health.
The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer.
Women with breast arterial calcifications are 51% more likely to develop heart disease or have a stroke, experts explained recently in Circulation: Cardiovascular Imaging.
In an exclusive video, Stacey Wolfson, MD, and Beatriu Reig, MD, MPH, from the NYU Grossman School of Medicine, discuss the findings of their new analysis.
There are not yet consensus-based guidelines available for screening women with dense breast tissue, so researchers at Mayo Clinic recently developed a set of recommendations regarding supplemental screening.
The analysis examined 620 cancer imaging studies from the top 25 imaging-related journals to come up with publication-to-incidence and publication-to-mortality ratios.
The latest U.S. Food and Drug Administration data on mammography systems installed nationwide shows DBT systems are rapidly replacing traditional 2D full field digital mammography units.
The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.
CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.
